DMD Celsis microsomes mean better data

Home Help [Feedback] [For Subscribers] [Archive] [Search] --
 QUICK SEARCH:   [advanced]


     


Drug Metabolism and Disposition Fast Forward
First published on December 6, 2006; DOI: 10.1124/dmd.106.012732


This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
dmd.106.012732v1
35/3/371    most recent
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wen, Z.
Right arrow Articles by Smith, P. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wen, Z.
Right arrow Articles by Smith, P. C.


Received for publication September 5, 2006.
Revised December 4, 2006.
Accepted for publication December 5, 2006.

UDP-glucuronosyltransferase 1A1 is the Principal Enzyme Responsible for Etoposide Glucuronidation in Human Liver and Intestinal Microsomes: Structural Characterization of Phenolic and Alcoholic Glucuronides of Etoposide and Estimation of Enzyme Kinetics

Zhiming Wen 1, Melanie N. Tallman 1, Shazia Y. Ali 1, Philip C. Smith 1*

1 UNC Chapel Hill

* Address correspondence to: E-mail: pcs{at}email.unc.edu

Abstract

Etoposide, an important anticancer agent, undergoes glucuronidation both in vitro and in vivo. In this study, three isomeric glucuronides of etoposide, including one phenolic (EPG) and two alcoholic glucuronides (EAG1 and EAG2), were biosynthesized in vitro with human liver microsomes (HLMs), and identified by liquid chromatography-electrospray ionization-mass spectrometry and confirmed by {beta}-glucuronidase cleavage. In vitro UDP-glucuronosyltransferase (UGT) reaction screening with 12 recombinant human UGTs demonstrated that etoposide glucuronidation is mainly catalyzed by UGT1A1. Although UGT1A8 and 1A3 also catalyzed the glucuronidation of etoposide, their activities were about 10 and 1% of UGT1A1. Enzyme kinetic study indicated that the predominant form of etoposide glucoronide in HLMs and human intestinal microsomes (HIMs) was EPG, whereas EAG1 and EAG2 were the minor metabolites, with approximately 8-10% glucuronidation rate of EPG. For the formation of EPG, the Vmax of HLMs (110 pmol/min/mg protein) was very similar to that of recombinant UGT1A1 (124 pmol/min/mg protein), whereas the Vmax of HIMs (54.4 pmol/min/mg protein) was 2-fold lower than those of HIMs and UGT1A1. The Km values of HLMs (530 µM) and HIMs (608 µM) were 2-fold higher than that of UGT1A1 (285 µM). The Vmax/Km values for the formation of EPG were 0.21 and 0.09 µl/min/mg protein for HLMs and HIMs, respectively. The data indicated that UGT1A1 is principally responsible for the formation of etoposide glucuronides, mainly in the form of phenolic glucuronide, suggesting that etoposide can be used as a highly selective probe substrate for human UGT1A1 in vitro.


Key words: enzyme kinetics, glucuronidation, mass spectrometry, metabolite identification, UDP glucuronyltransferases





Home Help [Feedback] [For Subscribers] [Archive] [Search] --
All ASPET Journals Molecular Pharmacology Pharmacological Reviews
 Molecular Interventions Drug Metabolism and Disposition

Copyright © 2006 by the American Society for Pharmacology and Experimental Therapeutics.